Two Sigma Investments, LP Iterum Therapeutics PLC Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.54 - $2.29 $285,418 - $1.21 Million	-528,553 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.97 - $2.39 $95,234 - $234,650	98,180 Added 22.81%	528,553 $1.22 Million
Q1 2021 May 17, 2021	BUY	$0.97 - $2.73 $417,461 - $1.17 Million	430,373 New	430,373 $607,000
Q4 2020 Feb 16, 2021	SELL	$0.46 - $1.2 $33,647 - $87,775	-73,146 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.58 - $1.22 $5,773 - $12,145	9,955 Added 15.75%	73,146 $77,000
Q2 2020 Aug 14, 2020	BUY	$1.19 - $4.38 $75,197 - $276,776	63,191 New	63,191 $75,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $23.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.